ÇѸ²´ëÇб³¼º½Éº´¿ø

±è³ª¿µ ±³¼ö

  • Áø·á°ú È£Èí±â-¾Ë·¹¸£±â³»°ú

Àü¹®Áø·áºÐ¾ß

¸¸¼º±âµµÁúȯ, õ½Ä, COPD, ±â°üÁöÈ®ÀåÁõ, °¨¿°¼º ÆóÁúȯ, Æó¾Ï Á¶±âÁø´Ü

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2026-03-02 ~ 2026-03-07)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ÇØ´ç ÀÇ·áÁøÀÇ ÁöÁ¤µÈ ½ºÄÉÁìÀÌ ¾ø½À´Ï´Ù.
¿ÀÈÄ
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2023.03 ~ 2025.02¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇÐ ¹Ú»ç ¼ö·á

2013.03 ~ 2017.02Á¦ÁÖ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼®»ç

°æ·Â

°æ·Â

ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø È£Èí±â¾Ë·¹¸£±â³»°ú °´¿øÁ¶±³¼ö

ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø È£Èí±â¾Ë·¹¸£±â³»°ú ÀüÀÓÀÇ

¼­¿ï´ëÇб³º´¿ø È£Èí±â³»°ú ÀüÀÓÀÇ

¼­¿ï´ëÇб³º´¿ø ³»°ú Àü°øÀÇ

¼­¿ï´ëÇб³º´¿ø ¼ö·ÃÀÇ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѳ»°úÇÐȸ Á¤È¸¿ø

´ëÇѰáÇÙ ¹× È£Èí±âÇÐȸ Á¤È¸¿ø, õ½Ä¿¬±¸È¸ ¿î¿µÀ§¿ø

´ëÇÑÁßȯÀÚÀÇÇÐȸ Á¤È¸¿ø

³í¹®

Clinical deterioration and lung function change in patients with concomitant asthma and bronchiectasis (The Journal of Allergy and Clinical Immunology: In Practice)
Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease (BMC Pulmonary Medicine)
Effect of chlorhexidine mouthrinse on prevention of microbial contamination during EBUS-TBNA: a randomized controlled trial (BMC Cancer)
Serum Zonulin is a biomarker for severe asthma (Allergy, Asthma & Immunology Research)
Biomarkers of particulate matter exposure in patients with chronic obstructive pulmonary disease: A Systematic review (Journal of Thoracic Disease)
Differential diagnosis of pleural effusion using machine learning (Annals of the American Thoracic Society)
Components of the COPD assessment test associated with the exacerbation of severe COPD patients (Respiration)
Risk factors of FEV1/FVC decline in COPD patients (Journal of Korean Medical Science)
Clinical characteristics of Pneumocystis jirovecii pneumonia in hemodialysis patients (Frontiers in Medicine)